drugset / Trial / NCT00575796
Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)
Phase 2
Unknown
50 enrolled
The Hospital for Sick Children
Brain Tumour Program · collabPediatric Oncology Group of Ontario · collab
NaSingle-groupOpen-labelTreatment
Summary
The overall objective of this study is to determine the efficacy of weekly Vinblastine in chemotherapy naïve patients with progressive or incompletely resected paediatric low grade glioma, to generate estimates of the response rate, progression-free survival, toxicity and quality of daily living among the population treated and determine biologic factors which will enable us to predict tumour behaviour.
Timeline
- Start
- 2007-10
- Primary completion
- 2018-10
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinblastine | Small molecule | 6 mg/m2 | Intravenous |